Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jasper Therapeutics

2.45
-0.2800-10.26%
Post-market: 2.520.0697+2.84%19:49 EDT
Volume:591.52K
Turnover:1.51M
Market Cap:36.80M
PE:-0.47
High:2.84
Open:2.75
Low:2.45
Close:2.73
52wk High:26.05
52wk Low:2.27
Shares:15.02M
Float Shares:9.14M
Volume Ratio:2.48
T/O Rate:6.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2498
EPS(LYR):-4.8865
ROE:-101.34%
ROA:-56.50%
PB:0.87
PE(LYR):-0.50

Loading ...

Jasper Therapeutics Inc expected to post a loss of $1.33 a share - Earnings Preview

Reuters
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

BTIG Reaffirms Their Buy Rating on Jasper Therapeutics (JSPR)

TIPRANKS
·
Jul 12

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx

Reuters
·
Jul 10

BUZZ-Jasper Therapeutics falls after halting clinical programs

Reuters
·
Jul 09

Jasper Therapeutics to reduce workforce by 50%, focus on Chronic Urticaria

TIPRANKS
·
Jul 09

Press Release: Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway

Dow Jones
·
Jul 09

Jasper Therapeutics (JSPR) Receives a Buy from Evercore ISI

TIPRANKS
·
Jul 08

TD Cowen Sticks to Their Buy Rating for Jasper Therapeutics (JSPR)

TIPRANKS
·
Jul 08

Jasper Therapeutics downgraded to Market Perform from Outperform at BMO Capital

TIPRANKS
·
Jul 08

Hold Rating for Jasper Therapeutics Amid Uncertainties in Briquilimab’s Clinical Trials and Competitive Challenges

TIPRANKS
·
Jul 08

Jasper Therapeutics Is Maintained at Buy by BTIG

Dow Jones
·
Jul 08

Jasper Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald

TIPRANKS
·
Jul 08

Buy Rating Maintained for Jasper Therapeutics Amid Manufacturing Setback and Promising Drug Profile

TIPRANKS
·
Jul 08

BUZZ-U.S. STOCKS ON THE MOVE-U.S. Bancorp, IonQ, BlackRock

Reuters
·
Jul 08

HC Wainwright Adjusts Price Target on Jasper Therapeutics to $20 From $40, Maintains Buy Rating

MT Newswires Live
·
Jul 07

Buy Rating Affirmed for Jasper Therapeutics Amid Promising Efficacy and Resolved Trial Setbacks

TIPRANKS
·
Jul 07

Jasper Therapeutics price target lowered to $20 from $40 at H.C. Wainwright

TIPRANKS
·
Jul 07

Sector Update: Health Care Stocks Lean Lower Premarket Monday

MT Newswires Live
·
Jul 07

BUZZ-Jasper Therapeutics plunges as co halts asthma trial due to drug lot issue

Reuters
·
Jul 07